Let the immune cell see the virus: Scientists discover unique way to target common virus
New type of antibody marks infected cells so immune system can see - and kill them
2021-02-16
(Press-News.org) Scientists at Cardiff University have discovered a unique way to target a common virus that affects one in 200 newborn babies in the UK but for which there is only limited treatments available.
Human cytomegalovirus (HCMV) is a master at "hiding" from the body's immune system so antibodies and T-cells cannot attack it as they do in other viruses, like the current coronavirus.
The researchers have now discovered a new type of antibody in the lab which - instead of killing the virus directly - marks infected cells so the immune system can "see" them.
Once the immune system can see the infected cells it is able to kill the virus.
The team have submitted a patent for the unique immunotherapeutic and hope it can help to treat HCMV, which can leave newborn babies severely disabled or even kill them.
Further work is needed to make sure it is safe and effective in humans - but the researchers hope the technique could eventually be used to fight other infectious diseases and the method they used to find the new antibody could be applied to cancer.
The study is published today in the Journal of Clinical Investigation.
Lead author Dr Richard Stanton, a virologist from Cardiff University's Division of Infection and Immunity, said: "HCMV is a major challenge because it has evolved a range of different techniques to avoid the body's own immune response.
"We have developed a really unique way of letting the immune system see the virus so it can get on with its task of killing it."
HCMV causes lifelong infection in humans and is a significant cause of severe disease or death in immunocompromised individuals, such as those undergoing transplants or people with HIV.
A vaccine is paramount to fighting the virus, particularly for tackling congenital disease, however there is currently no vaccine and only limited treatment options are available.
In this study, the researchers looked at whether antibody-dependent cellular cytotoxicity (ADCC) - a particular type of immune response in which a target cell is coated with antibodies and killed by immune cells - could be exploited for therapeutic use.
They used a special technique (proteomics) to characterise the molecules found on the surface of the infected cell and combined this with immunological screening to identify targets for ADCC.
They found a unique target expressed early in the virus's lifecycle and were then able to develop human antibodies for use against this target.
In the lab, this brought about a potent activation of ADCC, killing the infected cells.
"The identification of novel ADCC targets not only opens up a fuller understanding of natural immunity against HCMV that can be exploited for therapeutic benefit, but this could also now be applied to other infectious diseases - and the mechanism we used to pinpoint the new antibody could potentially also work in cancer," said Dr Stanton.
"Further work is now needed to demonstrate both safety and efficacy in humans."
INFORMATION:
* The study, Monoclonal antibodies targeting non-structural viral antigens can activate ADCC against human cytomegalovirus, can be accessed here as a PDF and will be available here after the embargo has passed
* Dr Richard Stanton is available for interview
For further information and interview requests contact:
* Gerry Holt, comms & marketing, Cardiff University - 029 2087 5596 or HoltG2@cardiff.ac.uk
Cardiff University is recognised in independent government assessments as one of Britain's leading teaching and research universities and is a member of the Russell Group of the UK's most research intensive universities. The 2014 Research Excellence Framework ranked the University 5th in the UK for research excellence. Among its academic staff are two Nobel Laureates, including the winner of the 2007 Nobel Prize for Medicine, Professor Sir Martin Evans. Founded by Royal Charter in 1883, today the University combines impressive modern facilities and a dynamic approach to teaching and research. The University's breadth of expertise encompasses: the College of Arts, Humanities and Social Sciences; the College of Biomedical and Life Sciences; and the College of Physical Sciences and Engineering, along with a longstanding commitment to lifelong learning. Cardiff's flagship Research Institutes are offering radical new approaches to pressing global problems. More at http://www.cardiff.ac.uk
ELSE PRESS RELEASES FROM THIS DATE:
2021-02-16
It does not happen often. But on rare occasions, physicians make mistakes and may make a wrong diagnosis. Patients may have many diseases all at once, where it can be difficult to distinguish the symptoms of one illness from the other, or there may be a lack of symptoms.
Errors in diagnosis may lead to incorrect treatment or a lack of treatment. Therefore, everyone in the healthcare system tries to minimise errors as much as possible.
Now, researchers at the University of Copenhagen have developed an algorithm that can help with just that.
'Our new algorithm can find the patients who have such an unusual disease trajectory that they may indeed not suffer from the disease ...
2021-02-16
Scientists have discovered that pollution concentration varies between seasons. A new study, conducted in the North China Plain, determined where volatile organic compounds (VOCs) are distributed within the vertical layers of the atmosphere, and found notable changes from winter to summer.
"The concentration of VOCs in the vertical direction was much higher in winter than that in summer and their emission sources showed different contributions in both seasons," said Guiqian Tang, associate professor in the Institute of Atmospheric Physics, Chinese Academy of Sciences, and the corresponding author of a study just published in Advances in Atmospheric Sciences .
The researchers conducted a field campaign from June 8 to July 3, 2019. They focused ...
2021-02-16
Researchers have used the zebrafish (Danio rerio) to identify the role of a gene involved in cardiac rhythm, which could help explain the fundamentals of what it takes to make a human heartbeat.
The University of Melbourne study also found that mutation of the gene, Tmem161b, causes potentially fatal cardiac arrhythmia. 2.5 per cent of Australians are living with cardiac arrhythmia ( END ...
2021-02-16
Almost half of people testing positive for coronavirus have reported symptoms of depression, according to a new study published in the International Journal of Environmental Research and Public Health.
Researchers from Bangladesh, the United States and Anglia Ruskin University (ARU) in the UK carried out a cross-sectional survey of more than 1,000 Bangladeshi adult coronavirus patients over the course of one month.
A total of 48% of respondents were categorised as having moderate to severe depression, with a higher prevalence in those with persistent symptoms, low family income ...
2021-02-16
Brain tumours are the most common solid tumours in childhood and the largest cause of death from cancer in this age group
Being able to classify a brain tumour's type, without the use of biopsy, is hard to do; however diffusion weighted imaging, an advanced imaging technique, when combined with machine learning, can help a UK-based multi-centre study, including WMG, University of Warwick has found.
Being able to characterise the tumour(s) faster and more accurately means they can be treated more efficiently
Diffusion weighted imaging and machine learning can successfully classify the diagnosis and characteristics of common types of paediatric brain tumours a UK-based multi-centre study, including WMG at the University of Warwick ...
2021-02-16
Researchers from North Carolina State University, Boston University and Kraton Corporation have demonstrated a family of self-sterilizing polymers that are effective at inactivating coronaviruses, including SARS-CoV-2 - the virus that causes COVID-19. The work opens the door to a suite of applications that could help to reduce the transmission of COVID-19 and other diseases.
"Our work here provides conclusive evidence that these materials, anionic polymers, can inactivate human coronaviruses quickly and efficiently," says Richard Spontak, co-author of a paper on the work accepted for publication in Advanced Science. Spontak is a Distinguished Professor of Chemical and Biomolecular Engineering and ...
2021-02-16
A team of soil scientists developed a new approach to the automatic generation and updating of soil maps. Having applied machine learning technologies to a set of rules traditionally used by experts in manual mapping, the team obtained a highly accurate model that provides easy-to-interpret results. The study was published in ISPRS International Journal of Geo-Information.
Many software solutions for digital soil mapping are based on statistical models. The accuracy of such programs is limited because statistical models depend on the quality and quantity of field data and can ignore local irregularities in soil properties. It is difficult to obtain accurate and useful information from ...
2021-02-16
TAMPA, Fla. - One of the most challenging issues in cancer therapy is the development of drug resistance and subsequent disease progression. In a new article featured on this month's cover of Cancer Research, Moffitt Cancer Center researchers, in collaboration with Oxford University, report results from their study using mathematical modeling to show that cell turnover impacts drug resistance and is an important factor that governs the success of adaptive therapy.
Cancer treatment options have increased substantially over the past few decades; however, many patients eventually develop drug resistance. Physicians strive to overcome resistance by either trying to target cancer cells through an alternative approach or targeting the resistance mechanism itself, but success with ...
2021-02-16
Oncotarget recently published "Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors" by Mortensen, et al. which reported that there is a growing interest in the antibody-based delivery of cytokines to the tumor environment as a means to boost the anti-cancer activity of tumor-resident T cells and NK cells.
Here, the authors described the expression and characterization of fusion proteins, featuring the L19 antibody and an engineered cytokine with interleukin-2 and interleukin-15 ...
2021-02-16
Oncotarget recently published "AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity" which reported that the authors investigated the expression and net effect of the individual isoforms in triple negative breast cancers and response to cisplatin treatment using cellular, mice models and clinical samples.
Interestingly, analysis of the expressions of AKT isoforms in clinical samples showed relatively higher expression of AKT1 in primary tissues; whereas lung and liver metastatic samples showed elevated ...
LAST 30 PRESS RELEASES:
[Press-News.org] Let the immune cell see the virus: Scientists discover unique way to target common virus
New type of antibody marks infected cells so immune system can see - and kill them
